Varied acceptance of clinical trial results

Atanasiu, 1956, Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in ion-exposed persons, Bull WHO, 14, 593 National Advisory Committee for the Evaluation of Gamma Globulin in the Prophylaxis of Poliomyelitis, 1954, An evaluation of the efficiency of gamma globulin in the prophylaxis of paralytic poliomyelitis as used in the United States, Public Health Monograph No 20 1970, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Part I: Design, methods and baseline characteristics, Diabetes, 19, 747 1970, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Part II: Mortality Results, Diabetes, 19, 787 1971, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenformin results, JAMA, 217, 771 1973, A study of the effects of hypoglycemic agents on vascular complications in patients with adult on-set diabetes. V: Evaluation of phenformin therapy, Diabetes, 24, 65 1978, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII: Mortality and selected nonfatal events with insulin treatment, JAMA, 240, 37, 10.1001/jama.1978.03290010041020 1982, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: Final report, Diabetes, 31, 1 1973, The Coronary Drug Project: Design, methods, and baseline results, Circulation, 47, I-1 1970, The Coronary Drug Project: Initial findings leading to modifications of its research protocol, JAMA, 214, 1303, 10.1001/jama.1970.03180070069012 1972, The Coronary Drug Project: Findings lead to further modifications of its protocol with respect to dextrothyroxine, JAMA, 220, 996, 10.1001/jama.1972.03200070084015 1973, The Coronary Drug Project: Findings leading to discontinuation of the 2.5 mg/day estrogen group, JAMA, 226, 652, 10.1001/jama.1973.03230060030009 1975, Clofibrate and niacin in coronary heart disease, JAMA, 231, 360, 10.1001/jama.1975.03240160024021 Canner, 1986, Fifteen year mortality in Coronary Drug Project patients: Long term benefit with niacin, J Am Coll Cardiol, 8, 1245, 10.1016/S0735-1097(86)80293-5 1980, Design, methods, and baseline results 1980, A randomized controlled trial of aspirin in persons recovered from myocardial infarction, JAMA, 243, 661, 10.1001/jama.1980.03300330019023 1980, Design, methods and baseline results, Circulation, II-1 1980, Persantine and aspirin in coronary heart disease, Circulation, 62, 449, 10.1161/01.CIR.62.3.449 Klimt, 1986, Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin, J. Am Coll Cardiol, 7, 251, 10.1016/S0735-1097(86)80489-2 1984, International Mexiletine and Placebo Antiarryhytmic Coronary Trial: I. Report on arrhythmia and other findings, J Am Coll Cardiol, 7, 1148 1981, Design, methods, and baseline results DRS Report Number 6, Invest Ophthalmol Vis Sci, 21, 149 1976, Preliminary report on effects of photocoagulation therapy, Am J Ophthalmol, 81, 383, 10.1016/0002-9394(76)90292-0 1978, Photocoagulation treatment of proliferative diabetic retinopathy: The second report of Diabetic Retinopathy Study findings, Ophthalmology, 85, 82, 10.1016/S0161-6420(78)35693-1 Olsen, 1989, The care of diabetic patients by ophthalmologists in New York State, Ophthalmology, 96, 739, 10.1016/S0161-6420(89)32815-6